By Teresa Conrivk
It was just in May that I reported on the very miraculous news that peanut allergies were being cured by the use of Lactobacillus Rhamnosus:
A strain of probiotic bacteria could offer a cure for potentially fatal peanut allergies, according to scientists in Australia. The breakthrough followed a trial in which a group of children were given increasing amounts of peanut flour, along with a probiotic called Lactobacillus rhamnosus, over an 18-month period. About 80 per cent of the children who had peanut allergies were subsequently able to tolerate peanuts.
I'm happy to report that new research is showing that the same bacteria strain has shown to be curing MILK allergies:
Probiotic formula reverses cow's milk allergies by changing gut bacteria of infants
- There has been an unprecedented increase in food allergies in developed countries, rising by as much as 20 percent in the past decade. Allergy to cow's milk is one of the most common, occurring in up to three percent of children worldwide.
- Emerging evidence suggests that modern environmental influences, including widespread antibiotic use, high-fat and low-fiber diets, reduced exposure to infectious diseases [ do they mean due to use of vaccines?] , Caesarean birth and formula feeding have altered the mutually beneficial relationship between humans and the bacteria that live in our gastrointestinal tract.
- ... infants with cow's milk allergy who are fed formula containing a form of the milk protein casein, supplemented with the probiotic bacterial species Lactobacillus rhamnosus GG (LGG), develop tolerance at higher rates than those treated with a non-probiotic formula.
- "This suggests a novel mechanism by which commensal bacteria regulate allergic responses to food."
- Overall, the gut microbiome of infants with a cow's milk allergy was significantly different than healthy controls, suggesting that differences in the structure of the bacterial community indeed influence the development of allergies.
- "The ability to identify bacterial strains that could be used as novel therapeutics for treating food allergies is a fundamental advance,"
Teresa Conrick is Contributing Editor to Age of Autism.